NSUN2 and breast carcinoma: These results demonstrate that NSUN2 overexpression in breast cancers tissues is related to ER-negative and PR-negative breast cancer subtypes, but, more importantly, NSUN2 may be a novel target for the development of effective treatment of these aggressive breast cancer types.